| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of osimertinib related hepatotoxicity, its successful desensitisation and re-challenge
|
Gray, Lucy
|
|
|
178 |
S1 |
p. S91
|
artikel
|
| 2 |
A case report of the abscopal effect in metastatic non-small cell lung cancer following irradiation of brain metastases without concurrent immunotherapy
|
Mehta, Ami
|
|
|
178 |
S1 |
p. S91-S92
|
artikel
|
| 3 |
A case study of an incidental finding of PJP on CBCT imaging in a stage III lung patient undergoing radical radiotherapy: a therapeutic radiographers experience
|
Stamp, Alexander
|
|
|
178 |
S1 |
p. S90-S91
|
artikel
|
| 4 |
Accelerating implementation of lung cancer screening in Australia: what evidence-based strategies are recommended?
|
Rankin, Nicole
|
|
|
178 |
S1 |
p. S66
|
artikel
|
| 5 |
Access to radical re-irradiation is essential to harness the benefit of follow-up in patients with non-small cell lung cancer (NSCLC) treated with curative intent
|
Valand, Dharmesh
|
|
|
178 |
S1 |
p. S62-S63
|
artikel
|
| 6 |
Adequacy of surveillance imaging following lung cancer resection surgery: are we following national clinical guidelines?
|
Mughal, Aishah
|
|
|
178 |
S1 |
p. S79-S80
|
artikel
|
| 7 |
A district general hospital experience of targeted lung health check pilot
|
Dixon, Giles
|
|
|
178 |
S1 |
p. S66-S67
|
artikel
|
| 8 |
Adjuvant immunotherapy after concurrent chemoradiation for locally advanced NSCLC: audit from Northern Ireland
|
McAleese, Jonathan
|
|
|
178 |
S1 |
p. S28
|
artikel
|
| 9 |
A feasibility study of high-dose twice-daily thoracic radiotherapy in limited stage small-cell lung cancer (LS-SCLC) at Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT)
|
Ball, Simon
|
|
|
178 |
S1 |
p. S75-S76
|
artikel
|
| 10 |
A multi-centre retrospective analysis of survival outcomes in metastatic NSCLC following WBRT to identify patients who may derive benefit from hippocampal avoidance
|
Bienz, Maya
|
|
|
178 |
S1 |
p. S62
|
artikel
|
| 11 |
Analyses of real-world data on patient outcomes in South Yorkshire, for patients with metastatic non-squamous lung cancer treated with pembrolizumab plus pemetrexed-platinum-based chemotherapy
|
Pang, Yan Ling Pang
|
|
|
178 |
S1 |
p. S37-S38
|
artikel
|
| 12 |
An evaluation of a new local anaesthetic thoracoscopy service in Edinburgh
|
Kelly, Sarah
|
|
|
178 |
S1 |
p. S16
|
artikel
|
| 13 |
An integrated Allied Healthcare Professional rehabilitation service for patients with thoracic cancer: an evaluation of patient’s rehabilitations needs post COVID-19, and service improvement project
|
Dickinson, Faye
|
|
|
178 |
S1 |
p. S42
|
artikel
|
| 14 |
A North East stage III, non-small cell lung cancer (NSCLC) multidisciplinary meeting (MDT) for shared decision making to optimise patient management: a prospective pilot study
|
Pickles, Rebecca
|
|
|
178 |
S1 |
p. S57
|
artikel
|
| 15 |
An update regarding the Meso-ORIGINS study (Mesothelioma Observational study of Risk prediction and Generation of paired benign-meso tissue samples, including a nested MRI Sub-Study): part of the PREDICT-Meso Accelerator
|
Neilly, Mark
|
|
|
178 |
S1 |
p. S21-S22
|
artikel
|
| 16 |
A population-adjusted indirect treatment comparison of efficacy and safety of aumolertinib vs osimertinib in EGFR-mutated non-small cell lung cancer
|
King, Sarah
|
|
|
178 |
S1 |
p. S36-S37
|
artikel
|
| 17 |
A Quality Improvement Project to Improve the Efficiency of Pulmonary Nodule Service at a Tertiary Centre
|
Khan, Muhammad Ziaullah
|
|
|
178 |
S1 |
p. S5
|
artikel
|
| 18 |
A regional clinical audit of the Greater Manchester NSCLC reflex testing protocol and genomic testing pathway
|
Goodley, Patrick
|
|
|
178 |
S1 |
p. S9
|
artikel
|
| 19 |
A regional clinical audit of the Greater Manchester NSCLC reflex testing protocol and genomic testing pathway: examining the downstream effects
|
Smith, Christopher
|
|
|
178 |
S1 |
p. S10
|
artikel
|
| 20 |
A regional clinical audit of the provision of adjuvant systemic anti-cancer treatment following lung cancer resection in eligible patients across Greater Manchester to support national benchmarking
|
Ugolini, Sara
|
|
|
178 |
S1 |
p. S28-S29
|
artikel
|
| 21 |
A retrospective evaluation of risk factors for and incidence of Pneumocystis jirovecii pneumonia (PJP) in Patients treated with continuous hyperfractionated accelerated radiotherapy (CHART) in the West of Scotland Cancer Centre
|
Fair, Katherine
|
|
|
178 |
S1 |
p. S64
|
artikel
|
| 22 |
A retrospective review of lung cancer patients receiving whole brain radiotherapy treated at the Kent Oncology Centre from June 2021 to June 2022
|
Davis, Nicola
|
|
|
178 |
S1 |
p. S61
|
artikel
|
| 23 |
A retrospective study of pneumonectomy lung cancer patients spanning a 20 year period
|
Ravishankar, Ramanish
|
|
|
178 |
S1 |
p. S83
|
artikel
|
| 24 |
Artificial-intelligence-based auto-contouring of tumour volumes for palliative lung cancer radiotherapy on planning CT data alone
|
Skett, Stephen
|
|
|
178 |
S1 |
p. S53-S54
|
artikel
|
| 25 |
A single centre retrospective audit of outcome of patients with EM4-ALK rearrangement positive metastatic non-small cell lung cancer (NSCLC)
|
Khan, Sam
|
|
|
178 |
S1 |
p. S32
|
artikel
|
| 26 |
Assessing the impact of the pharmacist independent prescriber as part of the multi-disciplinary care of patients receiving adjuvant treatment for NSCLC
|
Leggett, John
|
|
|
178 |
S1 |
p. S41
|
artikel
|
| 27 |
Audit of EBUS services in a district general hospital for confirmation of PD-L1 against national audit standards
|
Aulakh, Gagan Aulakh
|
|
|
178 |
S1 |
p. S14
|
artikel
|
| 28 |
Audit of real-life outcomes with PDL-inhibitors across the West of Scotland Cancer Network (WoSCAN) in non-small cell lung cancer (NSCLC)
|
Narwan, Sukhdeep
|
|
|
178 |
S1 |
p. S29-S30
|
artikel
|
| 29 |
A UK centre’s experience of stereotactic ablative radiotherapy (SABR) for very early-stage small-cell lung cancer (SCLC)
|
Oong, Zhu Chuen
|
|
|
178 |
S1 |
p. S75
|
artikel
|
| 30 |
Author index
|
|
|
|
178 |
S1 |
p. S94-S100
|
artikel
|
| 31 |
Baseline cardiovascular disease and risk of cardiac events following radical radiotherapy in NSCLC
|
Walls, Gerard
|
|
|
178 |
S1 |
p. S60
|
artikel
|
| 32 |
Better labelling and orientation of the thymic specimen to improve multimodality treatment
|
Bille, Andrea
|
|
|
178 |
S1 |
p. S52-S53
|
artikel
|
| 33 |
Bridging the gap: the challenge of mitigating health inequalities in lung cancer
|
Rintoul, Robert
|
|
|
178 |
S1 |
p. S48
|
artikel
|
| 34 |
BTOG Thymic Special Interest Group: Establishment of a national clinical network for thymic malignancies in the UK
|
Lynskey, Deirdre
|
|
|
178 |
S1 |
p. S4
|
artikel
|
| 35 |
Changes in diagnostic practice and stage at resection in non-small cell lung cancer during the COVID-19 pandemic: a four-year retrospective survey
|
Bell, Chris
|
|
|
178 |
S1 |
p. S40-S41
|
artikel
|
| 36 |
Characteristics and outcomes in patients with KRAS mutated lung adenocarcinomas: a retrospective data analysis
|
Zhang, Jingyao
|
|
|
178 |
S1 |
p. S34-S35
|
artikel
|
| 37 |
Clinical and Molecular profiling of KRAS G12C lung adenocarcinomas
|
Bulusu, Venkata
|
|
|
178 |
S1 |
p. S18
|
artikel
|
| 38 |
Communication matters! The value of patient information at times of change
|
Rawlinson, Janette
|
|
|
178 |
S1 |
p. S46
|
artikel
|
| 39 |
Community Access To Chest CT (CATCH): experiences from a tertiary centre of the CATCH CT protocol for equivocal chest radiographs requested in primary care
|
Broadhurst, Philip
|
|
|
178 |
S1 |
p. S7
|
artikel
|
| 40 |
Comparison of lung cancer staging data from Bradford and Craven (B&C) Targeted Lung Health Check (TLHC) programme with national statistics
|
Marjoram, Bethany
|
|
|
178 |
S1 |
p. S69
|
artikel
|
| 41 |
Comparison of VMAT (volumetric modulated arc therapy) delivery of high-dose palliative radiotherapy (RT) to lung via Eclipse Planning System (EPS), to conventional palliative radiotherapy delivery via ADW planning system
|
Walker, Sara
|
|
|
178 |
S1 |
p. S60-S61
|
artikel
|
| 42 |
CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in NSCLC
|
Horne, Ashley
|
|
|
178 |
S1 |
p. S86-S87
|
artikel
|
| 43 |
Contents
|
|
|
|
178 |
S1 |
p. iii
|
artikel
|
| 44 |
Copyright Page
|
|
|
|
178 |
S1 |
p. ii
|
artikel
|
| 45 |
CT characteristics of anterior mediastinal masses: can they be used to obviate percutaneous biopsies?
|
Anand, Krishna
|
|
|
178 |
S1 |
p. S52
|
artikel
|
| 46 |
Curative-intent treatment for lung cancer at Bradford Teaching Hospitals NHS Foundation Trust (BTHFT): influence of fitness testing and access to treatment
|
Iqbal, Imran
|
|
|
178 |
S1 |
p. S9-S10
|
artikel
|
| 47 |
30-day mortality after SACT (systemic anti-cancer therapy) for lung cancer at the Northern Trust SACT clinic (2019-2021)
|
Lau, Yan Hei
|
|
|
178 |
S1 |
p. S48
|
artikel
|
| 48 |
Developing a regional hub-and-spoke model for volumetric assessment of indeterminate pulmonary nodules supports efficient and effective management of pulmonary nodule pathways
|
Ratnakumar, Ratnaprashanthika
|
|
|
178 |
S1 |
p. S6-S7
|
artikel
|
| 49 |
Development and delivery of a second SABR service in Wales
|
Gibson, Victoria
|
|
|
178 |
S1 |
p. S18
|
artikel
|
| 50 |
Development of the Mesothelioma UK Clinical Trials app: a resource for patients and healthcare professionals
|
Taylor, Leah Taylor
|
|
|
178 |
S1 |
p. S25
|
artikel
|
| 51 |
Diagnostic rates of EBUS-TBNA in lung cancer patients at a large UK tertiary teaching hospital
|
Crisp, Elinor
|
|
|
178 |
S1 |
p. S13
|
artikel
|
| 52 |
Direct to CT screening pilot for patients with COPD in a deprived area: longitudinal analysis of the pulmonary nodule cohort outcomes
|
Dudzevicius, Vytis
|
|
|
178 |
S1 |
p. S68
|
artikel
|
| 53 |
Does consolidation radiotherapy to chest improve survival in extensive stage small cell lung cancer in the immunotherapy era? A retrospective study
|
Sylva, Rushan
|
|
|
178 |
S1 |
p. S66
|
artikel
|
| 54 |
Does pleurodesis leave patients at risk from malignant ascites or contralateral pleural effusions: a prevalence study?
|
Soo, Yiwen
|
|
|
178 |
S1 |
p. S47
|
artikel
|
| 55 |
Does prehabilitation provide a model for holistic long-term care? Early insights from a lung cancer feasibility study
|
Wade-Mcbane, Kelly
|
|
|
178 |
S1 |
p. S40
|
artikel
|
| 56 |
Dynamic monitoring of lung immune prognostic index (LIPI) in thoracic tumours treated with immune checkpoint inhibitors
|
Lopez Escola, Cristina
|
|
|
178 |
S1 |
p. S46
|
artikel
|
| 57 |
EBUS audit: assessing the diagnostic performance of the service at UHL
|
Mohammad, Syed
|
|
|
178 |
S1 |
p. S13
|
artikel
|
| 58 |
Editorial Board
|
|
|
|
178 |
S1 |
p. iv
|
artikel
|
| 59 |
Efficacy and safety of durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer: a single institution experience at University Hospital of North Midlands (UHNM) in the United Kingdom (UK)
|
Gilani, Shahid
|
|
|
178 |
S1 |
p. S25-S26
|
artikel
|
| 60 |
Efficacy and safety outcomes in patients receiving sotorasib for advanced KRAS G12C-mutated non-small cell lung cancer
|
Milner-Watts, Charlotte
|
|
|
178 |
S1 |
p. S31-S32
|
artikel
|
| 61 |
Embedding qualitative research in lung cancer trials: Thoracic Umbrella Radiotherapy Study in stage IV NSCLC: TOURIST
|
Calman, Lynn
|
|
|
178 |
S1 |
p. S88
|
artikel
|
| 62 |
Endobronchial ultrasound–transbronchial nodal aspiration (EBUS-TBNA) with rapid on-site evaluation (ROSE) in the Ulster Hospital, 2021
|
Jamaludin, Jasrul
|
|
|
178 |
S1 |
p. S14-S15
|
artikel
|
| 63 |
Establishing a population-tailored smoking cessation service in Gibraltar
|
Lopez Escola, Cristina
|
|
|
178 |
S1 |
p. S51
|
artikel
|
| 64 |
Establishment of a multidisciplinary prehabilitation programme for lung cancer patients at a district general hospital including: physical activity, dietary support, and psychological wellbeing
|
Ivey, Sarah
|
|
|
178 |
S1 |
p. S38
|
artikel
|
| 65 |
Evaluating a new, standardised regional referral proforma for new diagnoses of small cell lung cancer in Greater Manchester
|
Halkyard, Emma
|
|
|
178 |
S1 |
p. S38-S39
|
artikel
|
| 66 |
Evaluating safe prescribing with long-term steroid usage for checkpoint inhibitor (IO) toxicity in oncology patients
|
Mew, Rosie
|
|
|
178 |
S1 |
p. S33-S34
|
artikel
|
| 67 |
Evaluating the need for, and provision of, a dietetic service in patients with early-stage lung cancer
|
Desmond, Nicole
|
|
|
178 |
S1 |
p. S41-S42
|
artikel
|
| 68 |
Event-free survival (EFS) with neoadjuvant nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) versus chemo by surgical outcomes in resectable non-small cell lung cancer (NSCLC) from CheckMate 816
|
Spicer, Jonathan
|
|
|
178 |
S1 |
p. S26-S27
|
artikel
|
| 69 |
Every breath: the benefits of a lung cancer support group
|
DeLobel, Nicola
|
|
|
178 |
S1 |
p. S39
|
artikel
|
| 70 |
Feasibility of newly approved nivolumab-ipilimumab combination therapy for unresectable malignant mesothelioma in the Tayside population
|
Wilson, Abbie
|
|
|
178 |
S1 |
p. S20
|
artikel
|
| 71 |
Five years of adjuvant chemotherapy in a tertiary oncology centre: outcomes and impact of GCSF on completion of treatment
|
Gao, Jovia
|
|
|
178 |
S1 |
p. S36
|
artikel
|
| 72 |
Frailty and mortality in a regional UK lung SABR service: can we identify patients for frailty assessment and prehabilitation?
|
Main, Sean
|
|
|
178 |
S1 |
p. S54-S55
|
artikel
|
| 73 |
Genomic Laboratory Hubs (GLHs) in the predictive profiling of non-small cell lung cancer: adapting to centralisation and improving the pathways
|
Haragan, Alexander
|
|
|
178 |
S1 |
p. S2
|
artikel
|
| 74 |
Hamlet.rt Trans: a prospective single-centre translational sub-study evaluation of liquid biomarkers of radiation response
|
Denholm, Mary
|
|
|
178 |
S1 |
p. S88
|
artikel
|
| 75 |
Has GIRFT review helped improve stage 3 treatment rates in Wolverhampton?
|
Lakin, Kerry
|
|
|
178 |
S1 |
p. S57
|
artikel
|
| 76 |
Hemi-thoracic irradiation with proton therapy in malignant pleural mesothelioma (HIT-Meso)
|
Chan, Kitty Hiu Yu
|
|
|
178 |
S1 |
p. S86
|
artikel
|
| 77 |
How does the use of frailty scoring correlate to outcomes in older patients with lung cancer?
|
Hornby, Catherine
|
|
|
178 |
S1 |
p. S49
|
artikel
|
| 78 |
Immune-related thyroid dysfunction in lung cancer patients treated with PD-1/PD-L1 checkpoint inhibitors
|
Bulusu, Venkata
|
|
|
178 |
S1 |
p. S30
|
artikel
|
| 79 |
Immunotherapy-related adverse events (irAEs) in real world patients with advanced non-small cell lung cancer (aNSCLC) on chemoimmunotherapy: a Spinnaker study sub-analysis
|
Anpalakhan, Shobana
|
|
|
178 |
S1 |
p. S33
|
artikel
|
| 80 |
Impact and causes of readmission within 90-days of non-small cell lung cancer surgery
|
Roberts, Emily
|
|
|
178 |
S1 |
p. S47-S48
|
artikel
|
| 81 |
Impact of COVID-19 lockdown on new lung cancer diagnosis at the Royal Gwent Hospital
|
Elahi, Aarij
|
|
|
178 |
S1 |
p. S11
|
artikel
|
| 82 |
Impact of COVID 19 on EBUS services
|
Dugdale, Isobel
|
|
|
178 |
S1 |
p. S13-S14
|
artikel
|
| 83 |
Impact of perioperative fluids on clinical outcomes following thoracic surgery: a single-centre propensity matched retrospective study
|
Mughal, Aishah
|
|
|
178 |
S1 |
p. S78
|
artikel
|
| 84 |
Impact of pleural procedures on breathlessness and quality of life in malignant pleural effusions
|
Nixon, Rodanthe
|
|
|
178 |
S1 |
p. S50
|
artikel
|
| 85 |
Impact of prehabilitation on pre-operative function, post-operative complications and length of stay in resectable lung cancers
|
Finch, Alice
|
|
|
178 |
S1 |
p. S82-S83
|
artikel
|
| 86 |
Impact of the New Optimal Lung Cancer Pathway (NOLCP) at Cambridge University Hospitals (CUH) NHS Trust
|
Gordon, Laura
|
|
|
178 |
S1 |
p. S3-S4
|
artikel
|
| 87 |
Implementation of an antihypertensive deprescribing protocol in frail, stage IV lung cancer patients in clinical practice
|
Hilton, Juliette
|
|
|
178 |
S1 |
p. S44-S45
|
artikel
|
| 88 |
Implementation of a regional lung radiotherapy protocol in the UK
|
John, Susan
|
|
|
178 |
S1 |
p. S65-S66
|
artikel
|
| 89 |
Implementation of mid-ventilation scan for lung SABR planning
|
Brooke, Sarah
|
|
|
178 |
S1 |
p. S56
|
artikel
|
| 90 |
Implementing adjuvant immunotherapy following radical chemoradiotherapy for stage III non-small cell lung cancer in UK clinical practice: are the PACIFIC trial outcomes achievable in the real world?
|
Ahmed, Radwa Fawzy Saleh
|
|
|
178 |
S1 |
p. S27-S28
|
artikel
|
| 91 |
Implementing a sustainable lung SABR planning pathway: reducing inefficiencies and improving timeliness of treatment
|
Wooder, Rachael
|
|
|
178 |
S1 |
p. S54
|
artikel
|
| 92 |
Implementing heart-sparing radiotherapy for lung cancer
|
Marchant, Tom
|
|
|
178 |
S1 |
p. S55-S56
|
artikel
|
| 93 |
Implementing the Yorkshire Cancer Research funded Prehabilitation Radiotherapy Exercise smoking Habit cessation And Balanced diet Study (PREHABS): a therapeutic radiographer’s perspective
|
Morgan, Emma
|
|
|
178 |
S1 |
p. S39
|
artikel
|
| 94 |
Implementing the Yorkshire Cancer Research funded Prehabilitation Radiotherapy Exercise smoking Habit cessation And Balanced diet Study (PREHABS): the feasibility of embedding dietetic intervention into the radical lung radiotherapy pathway
|
Williams, Gillian
|
|
|
178 |
S1 |
p. S40
|
artikel
|
| 95 |
Improving patient selection and referral for CT-guided lung biopsy at a tertiary referral centre
|
Harrison, Mark
|
|
|
178 |
S1 |
p. S12
|
artikel
|
| 96 |
Improving the treatment pathway in small cell lung cancer
|
Palmer, Kieran
|
|
|
178 |
S1 |
p. S74
|
artikel
|
| 97 |
Improving the use of NOACS for cancer-related VTE in Great Western Hospital
|
Green, Seema
|
|
|
178 |
S1 |
p. S42-S43
|
artikel
|
| 98 |
Incidental findings arising from targeted lung health checks: a GP practice perspective
|
Ward, Ann
|
|
|
178 |
S1 |
p. S72
|
artikel
|
| 99 |
Increased proportion of patients diagnosed with lung cancer as a result of an acute hospital admission during the COVID-19 pandemic, and associated inequalities
|
Taylor, Rebecca
|
|
|
178 |
S1 |
p. S15-S16
|
artikel
|
| 100 |
Indwelling pleural catheter infections: a cautionary tale
|
Zubikarai, Garazi
|
|
|
178 |
S1 |
p. S77
|
artikel
|
| 101 |
Initial experience of CT guided percutaneous microwave ablation of lung metastasis in a district general hospital
|
Zaidi, Syed
|
|
|
178 |
S1 |
p. S43-S44
|
artikel
|
| 102 |
Initial experience of the West Suffolk immunotherapy MDT
|
Abdelrahman, Mayada
|
|
|
178 |
S1 |
p. S77
|
artikel
|
| 103 |
Integrating multiple biomarkers for early lung cancer detection in people undergoing CT screening: The iDx-Lung Study – initial correlates of demographics with analytical results
|
Muller, Dan
|
|
|
178 |
S1 |
p. S11-S12
|
artikel
|
| 104 |
Interim analysis of patient recruitment, compliance and experience using smart watches for cardiac monitoring following curative-intent radiotherapy to the thorax
|
Fendall Amaro, Philip
|
|
|
178 |
S1 |
p. S63-S64
|
artikel
|
| 105 |
Is an ERAS program applicable for VATS anatomical segmentectomies?
|
Guarino, Mauro
|
|
|
178 |
S1 |
p. S78-S79
|
artikel
|
| 106 |
Is every PET positive lesion a lung cancer? Eight years outcome from a tertiary care hospital
|
Arif, Salman
|
|
|
178 |
S1 |
p. S19
|
artikel
|
| 107 |
Is it time to ring an alarm among young adults with NSCLC? A decade of follow up from an Indian cohort
|
Saikia, Jyoutishman
|
|
|
178 |
S1 |
p. S7-S8
|
artikel
|
| 108 |
Is MET amplication an escape mechanism for even non-targetable mutations in lung cancer?
|
Vijayaraghavan, Pavitra
|
|
|
178 |
S1 |
p. S92
|
artikel
|
| 109 |
Is there a need for extended thromboprophylaxis after lung cancer resection? A single centre study
|
Arif, Salman
|
|
|
178 |
S1 |
p. S77
|
artikel
|
| 110 |
Liquid biopsy in advanced non-small cell lung cancer: a single centre experience
|
Cronin, Christopher
|
|
|
178 |
S1 |
p. S11
|
artikel
|
| 111 |
Long term follow up of patients referred to the lung two week wait pathway with haemoptysis and a normal CT: do we miss cancer?
|
Brackenborough, Kate Brackenborough
|
|
|
178 |
S1 |
p. S7
|
artikel
|
| 112 |
Looking back at role of therapeutic bronchoscopy during the COVID-19 pandemic
|
Wright, Matthew
|
|
|
178 |
S1 |
p. S45-S46
|
artikel
|
| 113 |
Lung cancer patients’ views on screening and experiences of treatment and care – findings from the Global Lung Cancer Coalition’s third annual global survey
|
McNamara, Aoife
|
|
|
178 |
S1 |
p. S43
|
artikel
|
| 114 |
Machine learning-based overall survival prediction of older patients with advanced thoracic cancer: an analysis of oncology and geriatric features as prognostic factors
|
Wu, Xiaorong
|
|
|
178 |
S1 |
p. S29
|
artikel
|
| 115 |
Malignant pleural fluid sample: does size matter?
|
Niazi, Muhammad Bilal Khan Niazi
|
|
|
178 |
S1 |
p. S16
|
artikel
|
| 116 |
Malignant pleural mesothelioma (MPM) diagnoses requiring multiple invasive biopsies in Aneurin Bevan University Health Board (ABUHB)
|
King, Gethin
|
|
|
178 |
S1 |
p. S23
|
artikel
|
| 117 |
MITOPE trial-in-progress: first-in-human dose-escalation and expansion study to evaluate mitochondrial PRX3 inhibition by RSO-021 in patients with mesothelioma and other advanced solid tumours
|
Naumov, George
|
|
|
178 |
S1 |
p. S90
|
artikel
|
| 118 |
Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): updated results from a phase 1/2 study
|
Popat, Sanjay
|
|
|
178 |
S1 |
p. S35
|
artikel
|
| 119 |
Molecular profiling of lung adenocarcinoma using a genomic laboratory hub approach: a single centre real-world experience
|
Yang, Yu-Hsuen
|
|
|
178 |
S1 |
p. S8-S9
|
artikel
|
| 120 |
Molecular profiling result turnaround times and its impact on clinical decision making in non-small cell lung cancer (NSCLC)
|
Perumal Thiagarajan, Arun Prasath
|
|
|
178 |
S1 |
p. S34
|
artikel
|
| 121 |
Moral distress in mesothelioma and lung cancer nurses during the COVID-19 pandemic: insights from a UK survey
|
Hargreaves, Sarah
|
|
|
178 |
S1 |
p. S25
|
artikel
|
| 122 |
Niraparib efficacy in patients with unresectable mesothelioma: a randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO (TRIALS IN PROGRESS)
|
Fennell, Dean
|
|
|
178 |
S1 |
p. S85-S86
|
artikel
|
| 123 |
Nodal upstaging in RATS (robotic assisted) versus VATS (video assisted) lobectomy for clinical N0 lung cancer: 3 years single centre experience
|
El-Zeki, Ahmed
|
|
|
178 |
S1 |
p. S84-S85
|
artikel
|
| 124 |
Non-metastatic small cell lung cancer: real-world data for patients receiving radical concurrent chemoradiotherapy
|
Josephides, Eleni
|
|
|
178 |
S1 |
p. S76
|
artikel
|
| 125 |
Nurse-led consent
|
Weston-Thomas, Rebecca
|
|
|
178 |
S1 |
p. S38
|
artikel
|
| 126 |
Online information about mental health and well-being for UK patients and carers living with mesothelioma: an internet search study
|
Sherborne, Virginia
|
|
|
178 |
S1 |
p. S24-S25
|
artikel
|
| 127 |
Optimisation of patients with lung cancer suitable for systemic anticancer therapy with physiotherapy and app-based support
|
Taylor, Anna
|
|
|
178 |
S1 |
p. S49-S50
|
artikel
|
| 128 |
Osimertinib in untreated EGFR-mutated advanced lung adenocarcinoma: real world data
|
Almusarhed, Manar
|
|
|
178 |
S1 |
p. S33
|
artikel
|
| 129 |
Outcome of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC)
|
Islam, Mohammad
|
|
|
178 |
S1 |
p. S55
|
artikel
|
| 130 |
Outcomes for patients with advanced stage NSCLC who completed immunotherapy and outcomes for those who subsequently progressed during follow-up: real world experience
|
Mason, Holly
|
|
|
178 |
S1 |
p. S30-S31
|
artikel
|
| 131 |
Outcomes for platinum doublet chemotherapy before and after first-line immune checkpoint inhibition in advanced non-small cell lung cancer (NSCLC)
|
Lewis, Jacob
|
|
|
178 |
S1 |
p. S34
|
artikel
|
| 132 |
Outcomes of open access to CT scanning in suspected lung malignancy in patients in Lincolnshire
|
Desilva, Sarah-Jane
|
|
|
178 |
S1 |
p. S17
|
artikel
|
| 133 |
Outcomes of patients in South Yorkshire with PDL-1 positive or negative locally advanced or metastatic squamous (NSCLC) treated with first line pembrolizumab in combination with carboplatin and paclitaxel
|
Meehan, Danielle
|
|
|
178 |
S1 |
p. S37
|
artikel
|
| 134 |
Outcomes of radical resection of advanced thymic malignancy
|
Billè, Andrea
|
|
|
178 |
S1 |
p. S81
|
artikel
|
| 135 |
Patient characteristics and treatment patterns in resectable early-stage NSCLC: UK subgroup analysis of a global real-world study
|
Escriu, Carles
|
|
|
178 |
S1 |
p. S17
|
artikel
|
| 136 |
Patient experience of consent for systemic anti-cancer therapies (SACT): perspectives of patients with lung cancer versus other cancers
|
Ryan, Megan
|
|
|
178 |
S1 |
p. S44
|
artikel
|
| 137 |
Patient outcomes following endovascular stent insertion for malignant superior vena-cava obstruction with a focus on anticoagulation practice
|
Walker, Joshua
|
|
|
178 |
S1 |
p. S2-S3
|
artikel
|
| 138 |
Patients undergoing endobronchial ultrasound for isolated thoracic lymphadenopathy 2017-2022
|
McNeill, Emma
|
|
|
178 |
S1 |
p. S14
|
artikel
|
| 139 |
Pembrolizumab induced cerebral and brainstem inflammation: a case report on a rare side effect
|
Kelly, Lisa
|
|
|
178 |
S1 |
p. S92-S93
|
artikel
|
| 140 |
Perceived barriers to curative treatment for patients with early stage lung cancer: a mixed methods study
|
Morgan, Helen
|
|
|
178 |
S1 |
p. S45
|
artikel
|
| 141 |
Physician-led US-guided biopsy
|
Rizvi, Syed Hasan Mustafa Rizvi
|
|
|
178 |
S1 |
p. S16-S17
|
artikel
|
| 142 |
Pneumonitis occurring in a patient with recurrent adenocarcinoma of the lung following a treatment schedule change from 3 weekly to 6 weekly immunotherapy with pembrolizumab
|
Lefas, Alicia
|
|
|
178 |
S1 |
p. S92
|
artikel
|
| 143 |
Prediction of next generation sequencing test failure in lung adenocarcinoma in a genomic laboratory hub setting
|
Zhang, Yu Zhi
|
|
|
178 |
S1 |
p. S1-S2
|
artikel
|
| 144 |
Predictive markers of recurrence following lung cancer resection with curative intent
|
Mehdi, Rana
|
|
|
178 |
S1 |
p. S83-S84
|
artikel
|
| 145 |
Predictors of dyspnoea in cancer patients after lung resection
|
Algaeed, Saffana
|
|
|
178 |
S1 |
p. S50
|
artikel
|
| 146 |
Preliminary results of a qualitative interview study investigating patients’ attitudes to radical re-irradiation of non-small cell lung cancer
|
Rulach, Robert
|
|
|
178 |
S1 |
p. S87
|
artikel
|
| 147 |
Preliminary review of the Lung One Stop Clinic in Greater Manchester
|
Hiu Nian Chung, Jonathan
|
|
|
178 |
S1 |
p. S8
|
artikel
|
| 148 |
PRIMALung (EORTC-1901-LCG): prophylactic cerebral irradiation or active brain magnetic resonance imaging surveillance in small-cell lung cancer patients
|
Dempsey, Clare
|
|
|
178 |
S1 |
p. S89
|
artikel
|
| 149 |
Process mining as a research tool to evaluate care pathways for patients with an indeterminate pulmonary nodule demonstrates the high variability between patient pathways across a region
|
Ratnakumar, Ratnaprashanthika
|
|
|
178 |
S1 |
p. S6
|
artikel
|
| 150 |
Psychological distress in lung cancer: patient self-assessment versus lung cancer nurse specialist (LCNS) judgement
|
Walker, Suzanne
|
|
|
178 |
S1 |
p. S76
|
artikel
|
| 151 |
Radical chemoradiation for stage III NSCLC patients with N3 disease: futile exercise or a fruitful venture?
|
Mummudi, Naveen
|
|
|
178 |
S1 |
p. S62
|
artikel
|
| 152 |
Radical treatment for patients with brain only oligometastatic non-small cell lung cancer- long term survival is possible
|
Pascoe, Abigail
|
|
|
178 |
S1 |
p. S59
|
artikel
|
| 153 |
Radiological changes and patterns of progression in unresectable stage III NSCLC treated with concurrent chemoradiotherapy (CCRT) and durvalumab
|
Patel, Rianne
|
|
|
178 |
S1 |
p. S59
|
artikel
|
| 154 |
Realistic medicine in the lung cancer pathway: an audit of clinical decision making around invasive diagnostic tests for patients who did not ultimately receive anticancer therapies
|
Fairfield, Catherine
|
|
|
178 |
S1 |
p. S19
|
artikel
|
| 155 |
Real world experience of hypofractionated radical radiotherapy for non-small cell lung cancer (NSCLC) during the COVID-19 pandemic: a well-tolerated radiotherapy schedule with acceptable progression-free (PFS) and overall survival (OS)
|
Jeyin, Nidhish
|
|
|
178 |
S1 |
p. S63
|
artikel
|
| 156 |
Real-world use of nivolumab plus ipilimumab in the management of diffuse pleural mesothelioma (DPM): experience from the county of Kent
|
Shanmugalingam, Thurkaa
|
|
|
178 |
S1 |
p. S20
|
artikel
|
| 157 |
Reducing inequalities in lung cancer: a new self-referral chest x-ray (SRCXR) service for symptoms that could be caused by lung cancer in Greater Manchester
|
Smith, Alexander
|
|
|
178 |
S1 |
p. S45
|
artikel
|
| 158 |
Reducing the risk of death from PJP after radical lung cancer radiotherapy: second round QI intervention
|
McAleese, Jonathan
|
|
|
178 |
S1 |
p. S64-S65
|
artikel
|
| 159 |
Reporting of coronary artery calcification in targeted lung health check: Bradford and Craven and North Kirklees programmes
|
Ng, LiJi
|
|
|
178 |
S1 |
p. S68-S69
|
artikel
|
| 160 |
Research-based tools to encourage and facilitate engagement with palliative care for patients and families living with mesothelioma
|
Hargreaves, Sarah
|
|
|
178 |
S1 |
p. S23-S24
|
artikel
|
| 161 |
Research on the road: taking lung cancer research to the patient
|
Muller, Dan
|
|
|
178 |
S1 |
p. S69-S70
|
artikel
|
| 162 |
Respiratory consultant triage of 2WW CT scans
|
Hulston, George
|
|
|
178 |
S1 |
p. S3
|
artikel
|
| 163 |
Rethinking continuity in primary care for people with mesothelioma
|
Couchman, Emilie
|
|
|
178 |
S1 |
p. S24
|
artikel
|
| 164 |
Retrospective data of concurrent chemoradiation (cCRT) and adjuvant immunotherapy for stage III non-small cell lung cancer (NSCLC): a single centre experience
|
Pickles, Rebecca
|
|
|
178 |
S1 |
p. S58
|
artikel
|
| 165 |
Retrospective review of patients receiving thoracic palliative radiotherapy (TRT) for non-small-cell lung cancer (NSCLC) in Weston Park Cancer Centre (WPCC): a real world regional cancer centre experience
|
Eardley, Jessica
|
|
|
178 |
S1 |
p. S61-S62
|
artikel
|
| 166 |
Retrospective review of patterns of recurrence in patients with a histological diagnosis of thymoma
|
Chong, Huili James
|
|
|
178 |
S1 |
p. S53
|
artikel
|
| 167 |
Review of local anaesthetic thoracoscopy services in Scotland
|
Middleton, Harry
|
|
|
178 |
S1 |
p. S23
|
artikel
|
| 168 |
Review of the practices of post-operative analgesic prescription after major lung resection for cancer: single centre study
|
Arif, Salman
|
|
|
178 |
S1 |
p. S79
|
artikel
|
| 169 |
Rollout of the Targeted Lung Health Check across the Northern Cancer Alliance and workforce planning for the additional lung cancer diagnoses
|
Mitchell, Daniel
|
|
|
178 |
S1 |
p. S68
|
artikel
|
| 170 |
Secondary care resource utilisation in patients with high PDL1 and advanced non-squamous non-small cell lung cancer (NSq-NSCLC): a comparison of single agent pembrolizumab with combination chemotherapy + pembrolizumab
|
Patel, Grisma
|
|
|
178 |
S1 |
p. S36
|
artikel
|
| 171 |
See through the symptoms: an innovative and inspiring awareness campaign
|
Montague, Debra
|
|
|
178 |
S1 |
p. S15
|
artikel
|
| 172 |
Six-year outcomes of subsolid nodules detected in the Manchester Lung Health Check screening pilot
|
Ahuja, Gaurav
|
|
|
178 |
S1 |
p. S70
|
artikel
|
| 173 |
Solitary fibrous tumours of the pleura causing mass effect
|
Mehdi, Rana
|
|
|
178 |
S1 |
p. S84
|
artikel
|
| 174 |
Stereotactic ablative radiotherapy (SABR) for lung oligometastases can prevent or delay need for systemic anti-cancer treatment (SACT): single institution experience
|
Lynch, Sophie
|
|
|
178 |
S1 |
p. S56-S57
|
artikel
|
| 175 |
Stereotactic radiosurgery (SRS) for oligometastatic brain metastases in patients with lung cancer: Northern Ireland audit
|
Ellis, Rachel
|
|
|
178 |
S1 |
p. S58
|
artikel
|
| 176 |
Subxiphoid uniportal 3D video-assisted thoracoscopic resection of a large anterior mediastinal mass and thymectomy
|
Lampridis, Savvas
|
|
|
178 |
S1 |
p. S90
|
artikel
|
| 177 |
Successful agile co-redesign of a personalised digital prehabilitation programme: Fit4Surgery app (F4S)
|
Alzahrani, Matar
|
|
|
178 |
S1 |
p. S81-S82
|
artikel
|
| 178 |
Surgery versus stereotactic ablative radiation therapy for stage I lung cancer: a real-world series
|
Josephides, Eleni
|
|
|
178 |
S1 |
p. S82
|
artikel
|
| 179 |
Surgical decompression of malignant spinal cord compression (MSCC) in lung cancer: the Manchester experience
|
Beckett, Holly
|
|
|
178 |
S1 |
p. S80-S81
|
artikel
|
| 180 |
Switching three weekly pembrolizumab to six weekly regimen during first peak of COVID: retrospective review from a DGH in Milton Keynes University Hospital
|
Saleem, Faiza
|
|
|
178 |
S1 |
p. S31
|
artikel
|
| 181 |
SYSTEMS-2: a randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma
|
Ashton, Miranda
|
|
|
178 |
S1 |
p. S22-S23
|
artikel
|
| 182 |
Targeted lung health check (TLHC) programme in Doncaster improves overall lung cancer staging at presentation
|
Kyi, Moe
|
|
|
178 |
S1 |
p. S73
|
artikel
|
| 183 |
Targeted lung health check (TLHC) programme outcomes: Doncaster experience
|
Kyi, Moe
|
|
|
178 |
S1 |
p. S73
|
artikel
|
| 184 |
The added value of screening for nutritional impact symptoms at the time of the new patient respiratory clinic for patients with suspected lung cancer
|
Maguire, Eleanor
|
|
|
178 |
S1 |
p. S72-S73
|
artikel
|
| 185 |
The effectiveness of offering ongoing and repeated provision of co-located, opt-out smoking cessation support as part of a lung cancer screening programme
|
Murray, Rachael
|
|
|
178 |
S1 |
p. S70-S71
|
artikel
|
| 186 |
The end of an era? Reduction in the use of prophylactic cranial irradiation (PCI) in limited disease small cell lung cancer (LD SCLC)
|
McAleese, Jonathan
|
|
|
178 |
S1 |
p. S75
|
artikel
|
| 187 |
The experience of a district general hospital when recruiting patients from across the region into a national study within a rare cancer
|
Bolton, Simon
|
|
|
178 |
S1 |
p. S19-S20
|
artikel
|
| 188 |
The experience of patients with thymic epithelial tumours: a survey of patient perception of support from their clinical team and beyond
|
Ruddock, Karen
|
|
|
178 |
S1 |
p. S53
|
artikel
|
| 189 |
The impact of military and civilian health partnership in raising awareness of asbestos exposure in military personnel and veterans
|
Moylan, Anne
|
|
|
178 |
S1 |
p. S4-S5
|
artikel
|
| 190 |
The impact of real-world lung cancer screening programmes on downstream diagnostic capacity
|
Sivabalah, Kavita
|
|
|
178 |
S1 |
p. S71
|
artikel
|
| 191 |
The impact of reminder invitations on participation in community-based lung cancer screening
|
Bailey, Hannah
|
|
|
178 |
S1 |
p. S67
|
artikel
|
| 192 |
The issue of no tissue: lung cancer patients without a tissue diagnosis in NHS Lothian
|
Hainey, Scott
|
|
|
178 |
S1 |
p. S10-S11
|
artikel
|
| 193 |
The Peninsula stage III non-small cell lung cancer audit: assessing the impact of COVID-19 on treatment decisions
|
Smith, Philippa
|
|
|
178 |
S1 |
p. S27
|
artikel
|
| 194 |
The Peninsula stage 3 non-small cell lung cancer audit: adjuvant durvalumab
|
Smith, Philippa
|
|
|
178 |
S1 |
p. S27
|
artikel
|
| 195 |
The RAPID-RT study: gauging opinions on the balance between improved survival and acceptable toxicities after radiotherapy in patients with lung cancer
|
Wicks, Kate
|
|
|
178 |
S1 |
p. S65
|
artikel
|
| 196 |
The RAPID-RT study: results from a citizens’ jury exploring acceptable consent methods for the collection and analysis of real-world patient data
|
Holley, Rebecca
|
|
|
178 |
S1 |
p. S89
|
artikel
|
| 197 |
The role of mediastinoscopy following EBUS
|
Nasr, Eman
|
|
|
178 |
S1 |
p. S12
|
artikel
|
| 198 |
The routine clinical use of electronic patient-reported outcome measures (ePROMs) for patients with lung cancer
|
Crockett, Cathryn
|
|
|
178 |
S1 |
p. S5-S6
|
artikel
|
| 199 |
The Scottish Mesothelioma Network: impact of a national multidisciplinary team on overall survival in malignant pleural mesothelioma
|
Tate, Matthew
|
|
|
178 |
S1 |
p. S21
|
artikel
|
| 200 |
The spectrum of MET exon 14 skipping alterations in a UK population
|
O’Sullivan, Hazel
|
|
|
178 |
S1 |
p. S32-S33
|
artikel
|
| 201 |
The utility of high-fidelity simulation in improving trainee confidence within the lung cancer multi-disciplinary team setting
|
Patel, Kishen
|
|
|
178 |
S1 |
p. S4
|
artikel
|
| 202 |
Thoracic umbrella radiotherapy study in stage IV NSCLC: TOURIST
|
Woolf, David
|
|
|
178 |
S1 |
p. S85
|
artikel
|
| 203 |
Thymic cancer: a retrospective single centre experience over 10 years
|
Arends, Lesley
|
|
|
178 |
S1 |
p. S51
|
artikel
|
| 204 |
Thymic tumour radiotherapy in the UK: an investigation of clinician choice of radiotherapy dose
|
Robinson, Stephen
|
|
|
178 |
S1 |
p. S52
|
artikel
|
| 205 |
Tissue stewardship in the genomic profiling of non-small cell lung cancer: making the best of not very much
|
Roughneen, Kyle
|
|
|
178 |
S1 |
p. S18-S19
|
artikel
|
| 206 |
Title Page
|
|
|
|
178 |
S1 |
p. i
|
artikel
|
| 207 |
Trends in the use of first line systemic anti-cancer treatment for NSCLC between 2012 and 2022
|
Abdelrahman, Mayada
|
|
|
178 |
S1 |
p. S29
|
artikel
|
| 208 |
Two years on: progression free survival analysis of patients with advanced small cell lung cancer receiving atezolizumab plus etoposide and carboplatin in a tertiary oncology centre
|
Burney, Rebecca
|
|
|
178 |
S1 |
p. S74
|
artikel
|
| 209 |
Understanding the mental health and well-being impacts and interventions related to living with mesothelioma: a systematic review
|
Sherborne, Virginia
|
|
|
178 |
S1 |
p. S24
|
artikel
|
| 210 |
Using heart contour volume variability as natural experiment to test the effect heart sparing
|
van Herk, Marcel
|
|
|
178 |
S1 |
p. S59-S60
|
artikel
|
| 211 |
Well-differentiated lung neuroendocrine tumours: concordance between histological findings in pre-operative biopsies and post-operative pathology including ki67 proliferation index
|
Ahuja, Gaurav
|
|
|
178 |
S1 |
p. S48-S49
|
artikel
|
| 212 |
Well-differentiated lung neuroendocrine tumours: outcomes from 10 years of lung resections at a regional thoracic surgical centre 2012–2022
|
Ahuja, Gaurav
|
|
|
178 |
S1 |
p. S80
|
artikel
|
| 213 |
When to re-invite initially ineligible populations for lung cancer screening? Modelling from Manchester Lung Health Check cohorts
|
Goodley, Patrick
|
|
|
178 |
S1 |
p. S71-S72
|
artikel
|
Tijdschrift beschrijving